Seattle, WA, United States of America

Thomas O Daniel



Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Thomas O Daniel: A Pioneer in Endothelial Stem Cell Research

Introduction: Thomas O Daniel, an innovative inventor based in Seattle, WA, has made significant contributions to the field of stem cell research. With one patent to his name, he has demonstrated a keen understanding of endothelial stem cells and their potential applications in medicine.

Latest Patents: Thomas O Daniel's sole patent, titled "Endothelial stem cells, populations, methods of isolation and use thereof," focuses on stem cells that possess the unique ability to renew themselves and differentiate into endothelial or endothelial-like cells. This patent not only details methods for isolating these stem cells but also outlines various ways in which they can be utilized in medical treatments. Additionally, the patent provides information about progeny cells derived from these innovative stem cells, further enhancing their potential in therapeutic applications.

Career Highlights: Currently employed at Immunex Corporation, Thomas has utilized his expertise in stem cell research to contribute to the company's advancements in biotechnology. His work has played a crucial role in positioning Immunex as a leader in innovative medical solutions.

Collaborations: Throughout his career, Thomas O Daniel has collaborated with various professionals, including his coworker Anne-Marie C Rousseau. These partnerships have fostered a creative environment that encourages the sharing of knowledge and the development of groundbreaking ideas in stem cell research.

Conclusion: Thomas O Daniel stands out as an innovative inventor dedicated to advancing the field of endothelial stem cell research. His patent reflects a commitment to creating practical solutions in medicine. As he continues to work with Immunex Corporation and collaborators, the potential for further breakthroughs remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…